BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 12590458)

  • 1. Homology similarity analysis of sequences of lactoferricin and its derivatives.
    Nakai S; Chan JC; Li-Chan EC; Dou J; Ogawa M
    J Agric Food Chem; 2003 Feb; 51(5):1215-23. PubMed ID: 12590458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions of lactoferricin-derived peptides with LPS and antimicrobial activity.
    Farnaud S; Spiller C; Moriarty LC; Patel A; Gant V; Odell EW; Evans RW
    FEMS Microbiol Lett; 2004 Apr; 233(2):193-9. PubMed ID: 15063486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variation in antimicrobial activity of lactoferricin-derived peptides explained by structure modelling.
    Farnaud S; Patel A; Odell EW; Evans RW
    FEMS Microbiol Lett; 2004 Sep; 238(1):221-6. PubMed ID: 15336425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simple parameterization of non-proteinogenic amino acids for QSAR of antibacterial peptides.
    Lejon T; Svendsen JS; Haug BE
    J Pept Sci; 2002 Jul; 8(7):302-6. PubMed ID: 12148779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three-dimensional solution structure of lactoferricin B, an antimicrobial peptide derived from bovine lactoferrin.
    Hwang PM; Zhou N; Shan X; Arrowsmith CH; Vogel HJ
    Biochemistry; 1998 Mar; 37(12):4288-98. PubMed ID: 9521752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the cationic antimicrobial peptide lactoferricin fused with the anionic peptide in Escherichia coli.
    Kim HK; Chun DS; Kim JS; Yun CH; Lee JH; Hong SK; Kang DK
    Appl Microbiol Biotechnol; 2006 Sep; 72(2):330-8. PubMed ID: 16421719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of a 2-arylsulphonylated tryptophan: the antibacterial activity of bovine lactoferricin peptides containing Trp(2-Pmc).
    Haug BE; Andersen J; Rekdal O; Svendsen JS
    J Pept Sci; 2002 Jul; 8(7):307-13. PubMed ID: 12148780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of antibiotic activity and synthesis of new pentadecapeptides based on lactoferricins.
    Lejon T; Stiberg T; Strøm MB; Svendsen JS
    J Pept Sci; 2004 Jun; 10(6):329-35. PubMed ID: 15214437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stochastic-based descriptors studying biopolymers biological properties: extended MARCH-INSIDE methodology describing antibacterial activity of lactoferricin derivatives.
    de Armas RR; Díaz HG; Molina R; Uriarte E
    Biopolymers; 2005 Apr; 77(5):247-56. PubMed ID: 15682438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-complement effects of lactoferrin-derived peptides.
    Samuelsen Ø; Haukland HH; Ulvatne H; Vorland LH
    FEMS Immunol Med Microbiol; 2004 Jun; 41(2):141-8. PubMed ID: 15145458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of charge and lipophilicity on the antibacterial activity of undecapeptides derived from bovine lactoferricin.
    Strøm MB; Rekdal O; Svendsen JS
    J Pept Sci; 2002 Jan; 8(1):36-43. PubMed ID: 11831560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibacterial activity of peptides homologous to a loop region in human lactoferrin.
    Odell EW; Sarra R; Foxworthy M; Chapple DS; Evans RW
    FEBS Lett; 1996 Mar; 382(1-2):175-8. PubMed ID: 8612745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic activity of pentadecapeptides modelled from amino acid descriptors.
    Lejon T; Strøm MB; Svendsen JS
    J Pept Sci; 2001 Feb; 7(2):74-81. PubMed ID: 11277499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of shortening lactoferrin derived peptides against tumour cells, bacteria and normal human cells.
    Yang N; Strøm MB; Mekonnen SM; Svendsen JS; Rekdal O
    J Pept Sci; 2004 Jan; 10(1):37-46. PubMed ID: 14959890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibacterial activity of 15-residue lactoferricin derivatives.
    Strøm MB; Rekdal O; Svendsen JS
    J Pept Res; 2000 Nov; 56(5):265-74. PubMed ID: 11095180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural studies and model membrane interactions of two peptides derived from bovine lactoferricin.
    Nguyen LT; Schibli DJ; Vogel HJ
    J Pept Sci; 2005 Jul; 11(7):379-89. PubMed ID: 15635665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic porcine lactoferricin with a 20-residue peptide exhibits antimicrobial activity against Escherichia coli, Staphylococcus aureus, and Candida albicans.
    Chen HL; Yen CC; Lu CY; Yu CH; Chen CM
    J Agric Food Chem; 2006 May; 54(9):3277-82. PubMed ID: 16637685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bulky aromatic amino acids increase the antibacterial activity of 15-residue bovine lactoferricin derivatives.
    Haug BE; Skar ML; Svendsen JS
    J Pept Sci; 2001 Aug; 7(8):425-32. PubMed ID: 11548058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multimerization and fusion expression of bovine lactoferricin derivative LfcinB15-W4,10 in Escherichia coli.
    Tian ZG; Teng D; Yang YL; Luo J; Feng XJ; Fan Y; Zhang F; Wang JH
    Appl Microbiol Biotechnol; 2007 May; 75(1):117-24. PubMed ID: 17225098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short linear cationic antimicrobial peptides: screening, optimizing, and prediction.
    Hilpert K; Fjell CD; Cherkasov A
    Methods Mol Biol; 2008; 494():127-59. PubMed ID: 18726572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.